DE3852710D1 - Therapeutische Nukleoside. - Google Patents

Therapeutische Nukleoside.

Info

Publication number
DE3852710D1
DE3852710D1 DE3852710T DE3852710T DE3852710D1 DE 3852710 D1 DE3852710 D1 DE 3852710D1 DE 3852710 T DE3852710 T DE 3852710T DE 3852710 T DE3852710 T DE 3852710T DE 3852710 D1 DE3852710 D1 DE 3852710D1
Authority
DE
Germany
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3852710T
Other languages
English (en)
Other versions
DE3852710T2 (de
Inventor
George Walter Koszalka
Thomas Anthony Krenitsky
Janet Litster Rideout
Charlene Louise Burns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878708512A external-priority patent/GB8708512D0/en
Priority claimed from GB878712691A external-priority patent/GB8712691D0/en
Priority claimed from GB878723013A external-priority patent/GB8723013D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3852710D1 publication Critical patent/DE3852710D1/de
Publication of DE3852710T2 publication Critical patent/DE3852710T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3852710T 1987-04-09 1988-04-08 Therapeutische Nukleoside. Expired - Fee Related DE3852710T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878708512A GB8708512D0 (en) 1987-04-09 1987-04-09 Therapeutic nucleosides
GB878712691A GB8712691D0 (en) 1987-05-29 1987-05-29 Therapeutic nucleosides
GB878723013A GB8723013D0 (en) 1987-09-30 1987-09-30 Therapeutic nucleosides

Publications (2)

Publication Number Publication Date
DE3852710D1 true DE3852710D1 (de) 1995-02-23
DE3852710T2 DE3852710T2 (de) 1995-05-24

Family

ID=27263377

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3852710T Expired - Fee Related DE3852710T2 (de) 1987-04-09 1988-04-08 Therapeutische Nukleoside.

Country Status (20)

Country Link
US (1) US5068320A (de)
EP (1) EP0286425B1 (de)
JP (1) JP2763888B2 (de)
KR (1) KR880012630A (de)
AP (1) AP78A (de)
AT (1) ATE116984T1 (de)
AU (1) AU608590B2 (de)
CA (1) CA1326237C (de)
CS (1) CS274461B2 (de)
DE (1) DE3852710T2 (de)
DK (1) DK191688A (de)
FI (1) FI87214C (de)
HU (1) HU201954B (de)
IL (1) IL86007A0 (de)
MC (1) MC1915A1 (de)
NO (1) NO171641C (de)
NZ (1) NZ224189A (de)
PL (1) PL154956B1 (de)
PT (1) PT87191B (de)
RU (1) RU1779256C (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185437A (en) * 1987-04-09 1993-02-09 Burroughs Wellcome Co. Therapeutic nucleosides
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
US5077280A (en) * 1988-04-12 1991-12-31 Brown University Research Foundation Treatment of viral infections
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
DE68907013D1 (de) * 1988-10-24 1993-07-15 Wellcome Found Guaninderivate mit antiviraler wirkung und deren pharmazeutisch vertraegliche salze.
AU4817490A (en) * 1988-11-29 1990-06-26 Institut Fur Molekularbiologie Und Analytik (Ima) G.M.B.H. 2',3'-dideoxyribofuranosides and process for producing them
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法
US5585364A (en) * 1989-04-13 1996-12-17 British Technology Group Limited Antiviral compounds
US5013829A (en) * 1989-04-26 1991-05-07 University Of Iowa Research Foundation Stable congener of 2',3'-dideoxyadenosine
DE4020529A1 (de) * 1989-09-12 1991-03-21 Roxana Vasiloiu Multifunktionelle(s) enzym(e) mit nucleosid-didesoxyribosyltransferase(n) und/oder nucleoside-desoxyribosyltransferasen(n) und/oder kinease- und/oder reduktase- und/oder desaminase- und/oder polymerase-aktivitaet
JPH0637391B2 (ja) * 1989-09-29 1994-05-18 日本製紙株式会社 抗エイズウイルス剤
PT95516A (pt) * 1989-10-06 1991-08-14 Wellcome Found Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos
EP0544668A1 (de) * 1990-02-09 1993-06-09 THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE 6-fluor-9- (2,3-dideoxy-b-d-glycero-pentofuranosyl)-9h-purine und ihre verwendung als antivirale agenzien)
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
ID30477A (id) * 1998-12-23 2001-12-13 Shire Biochem Inc Analog nukleosida antivirus
CN101220071B (zh) * 2008-01-17 2011-04-06 南京长澳医药科技有限公司 稳定的6-甲氧基-2’,3’-双脱氧鸟嘌呤核苷及其制备方法和包含它的药物组合物
CN102234280B (zh) * 2010-04-26 2014-01-08 北京大学 D,l-鸟嘌呤核苷类似物及其制备方法和应用
BR112013005872A2 (pt) 2010-09-22 2019-09-24 Alios Biopharma Inc compostos, composição farmacêutica e respectivos usos
CA2837207A1 (en) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
WO2013096680A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
NZ631601A (en) 2012-03-21 2016-06-24 Alios Biopharma Inc Solid forms of a thiophosphoramidate nucleotide prodrug
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
BR112015021677A2 (pt) * 2013-03-05 2017-07-18 Hoffmann La Roche inibidores de tirosina quinase de bruton

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
ATE44464T1 (de) * 1985-03-16 1989-07-15 Wellcome Found Antivirale nukleoside.
CA1314875C (en) * 1985-05-15 1993-03-23 George Walter Koszalka Therapeutic nucleosides
JPS62501777A (ja) * 1985-08-26 1987-07-16 アメリカ合衆国 ２′，３′―ジデオキシシチジンを含有する抗ｈｔｌｖ―３／ｌａｖ剤
EP0217580A3 (de) * 1985-09-17 1990-11-07 The Wellcome Foundation Limited Therapeutische Nukleoside
IT1203558B (it) * 1986-05-20 1989-02-15 Firestone Int Dev Spa Metodo per la realizzazione di un pneumatico radiale di prima fase per veicoli
EP0342203B1 (de) * 1987-03-24 1994-07-06 Nycomed Imaging As 2',3'-dideoxyribofuranoxid-derivate
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
NZ225447A (en) * 1987-07-20 1991-12-23 Merck & Co Inc Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions

Also Published As

Publication number Publication date
NO881537D0 (no) 1988-04-08
PT87191A (pt) 1988-05-01
DE3852710T2 (de) 1995-05-24
FI87214C (fi) 1992-12-10
EP0286425B1 (de) 1995-01-11
IL86007A0 (en) 1988-09-30
PT87191B (pt) 1993-02-26
AU1444488A (en) 1988-10-13
NO171641C (no) 1993-04-14
NO171641B (no) 1993-01-04
AP78A (en) 1990-03-12
FI881651A0 (fi) 1988-04-08
PL154956B1 (en) 1991-10-31
KR880012630A (ko) 1988-11-28
HUT48269A (en) 1989-05-29
EP0286425A2 (de) 1988-10-12
JP2763888B2 (ja) 1998-06-11
CS242188A2 (en) 1990-09-12
NO881537L (no) 1988-10-10
US5068320A (en) 1991-11-26
FI87214B (fi) 1992-08-31
AU608590B2 (en) 1991-04-11
DK191688A (da) 1988-10-10
JPS63267796A (ja) 1988-11-04
AP8800086A0 (en) 1988-02-01
ATE116984T1 (de) 1995-01-15
DK191688D0 (da) 1988-04-08
HU201954B (en) 1991-01-28
PL271722A1 (en) 1989-01-23
CA1326237C (en) 1994-01-18
CS274461B2 (en) 1991-04-11
MC1915A1 (fr) 1989-04-06
NZ224189A (en) 1991-09-25
FI881651A (fi) 1988-10-10
RU1779256C (ru) 1992-11-30
EP0286425A3 (en) 1990-12-05

Similar Documents

Publication Publication Date Title
MX9203418A (es) Nucleosidos terapeuticos.
ATE116648T1 (de) Therapeutische nucleoside.
NL990028I2 (nl) Therapeutische nucleosiden.
DE3852710T2 (de) Therapeutische Nukleoside.
DK564088D0 (da) Nukleosidderivater
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
FI875039A (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
DE3788873T2 (de) Massagegerät.
MX9203420A (es) Nucleosidos terapeuticos.
DE3872028T2 (de) Therapeutische nucleoside.
ATE77386T1 (de) Therapeutische nucleoside.
DK725088A (da) Terapeutiske nucleosider
FI871028A0 (fi) Slirskydd med kombinationsstomme foer fordonsdaeck.
ATE104675T1 (de) Therapeutische nucleoside.
ES1003952Y (es) Pulsera terapeutica.
FI870853A0 (fi) Torkstaellning med flaekt.
FI870526A0 (fi) Trevaegsventil med gummislang.
FI870144A0 (fi) Uppvaermningsanordning med staolplaotskonstruktion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee